Dr. Rushing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
535 Barnhill Dr
Rt473
Indianapolis, IN 46202Phone+1 317-948-8310Fax+1 317-944-3646- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1979 - 1981
- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1979
- University of Illinois College of MedicineClass of 1976
Certifications & Licensure
- IL State Medical License 1977 - Present
- IN State Medical License 2000 - 2023
- WI State Medical License 1981 - 2001
- MN State Medical License 1979 - 1981
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
- A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Publications & Presentations
PubMed
- 12 citationsA Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the...Richard F. Riedel, Karla V. Ballman, Yao Lu, Steven Attia, Elizabeth T. Loggers, Kristen N. Ganjoo, Michael B. Livingston, Warren Chow, Jennifer Wright, John Harris Wa...> ;The Oncologist. 2020 Nov 1
- 2 citationsPharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma.Victor M. Villalobos, Gary Mo, Mark Agulnik, Seth M. Pollack, Daniel A. Rushing, Arun S. Singh, Brian A. Van Tine, Rhian McNaughton, Rodney Decker, Wei Zhang, Ashwin S...> ;Cancer Medicine. 2020 Feb 1
- 43 citationsOverall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarco...Shreyaskumar Patel, Margaret von Mehren, Damon R. Reed, Pamela E. Kaiser, John A. Charlson, Christopher W. Ryan, Daniel A. Rushing, Michael B. Livingston, Arun S. Sing...> ;Cancer. 2019 Aug 1
- Join now to see all
Hospital Affiliations
- Eskenazi HealthIndianapolis, Indiana
- Richard L. Roudebush Veterans Affairs Medical CenterIndianapolis, Indiana
- Indiana University Health University HospitalIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: